A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Sep, 30 2025
Oct, 15 2025
Nov, 17 2025
Oct, 21 2025
Jul, 3 2026